Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
Everyone at Kite is grounded by one common goal – curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work.
We are creating Kite together, with the recognition that the best teams are built by the best people. We maintain an attitude of curiosity, and creativity with each challenge as we develop a new market for cancer therapies. We appreciate and respect one another, and most importantly, we don’t take success for granted. While we’ve come a long way to make what others viewed as impossible, possible, we know one thing is certain. Today is just the beginning.
We are seeking a highly motivated and passionate individuals to join our Summer Internship Program! As an intern at Kite, you’ll have the unique opportunity to learn about cell therapy from some of the brightest minds in biotech while making a meaningful impact. We’re committed to developing early talent, and we welcome motivated individuals with a passion for transforming the way cancer is treated. The program also offers the opportunity for networking within Kite and Gilead, social events with fellow interns and Kite leadership as well as career development trainings while providing competitive compensation and relocation assistance for eligible candidates.
The Role
The individual in this intern position will work closely with FP&A finance leadership teams on several key projects during the summer of 2023. This can include supporting commercial, R&D and technical operations FP&A, although the exact project is TBD. Because the role will be matrixed across the groups, this person will report directly to the Head of Corporate FP&A who will manage the projects with the Finance Team Leads.
Responsibilities will include, but are not limited to, the following:
Detailed commercial market assessments and comparables to other CAR-T/relevant biotechs
Research and Development study cost tool working across Kite and Gilead organizations
Clinical manufacturing cost review and analysis working with Technical Operations finance lead
Other ad hoc requests
Basic Qualifications:
Must be at least 18 years or older
Must have a minimum GPA of 2.8
Must be currently enrolled in a full-time undergraduate degree program at an accredited university/college
Must have completed at least one year of study at an accredited university/college prior to internship commencing
Must be enrolled in the Fall Semester at an accredited university/college after the completion of the internship - graduation date of December 2022 or Spring/Summer 2023
Must be able to complete a 10-12 consecutive week internship between June and September
Must be eligible to work in the US and will not require future sponsorship by Kite, a Gilead Company
Must be able to work remotely or relocate if necessary and work at the designated site for the duration of the internship
Must not be employed at the time the internship starts
Preferred Qualifications:
Currently enrolled in bachelor’s degree with emphasis in Finance and/or Business
Proficiency with MS Office Suite
Ability to identify issues and seek solutions
Ability to work both independently and collaboratively/Ability to work in collaborate in cross functional teams in fast pace, dynamic team setting
Efficient, organized, and able to handle short timelines in a fast-paced environment
Experience and/or interest in the Biotechnology, Pharmaceutical or health-care industry
Knowledge and understanding of Good Manufacturing Practices (GMP) and regulatory policies
Experience with ERP systems such as Oracle EBS or SAP
Foster City, CA
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company’s products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.
It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of HIV/AIDS and liver diseases, hematology/oncology, inflammation/respiratory diseases, and others.
The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Scholar Rock Holding Corporation; Tango Therapeutics; National Cancer Institute; Pfizer, Inc.; Sangamo Therapeutics, Inc.; Gadeta B.V.; HiFiBiO Therapeutics; Agenus Inc.; HOOKIPA Pharma Inc.; Goldfinch Bio, Inc.; and insitro Inc. The company was founded in 1987 and is headquartered in Foster City, California.